Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia : Primary analysis of the randomized, open-label mable study
-
Michallet, Anne-Sophie (CLCC Centre Léon Bérard)
;
Aktan, Melih (Istanbul University) ;
Hiddemann, Wolfgang (Ludwig- Maximilians University of Munich) ;
Ilhan, Osman (Ankara University School of Medicine) ;
Johansson, Peter (Uddevalla Hospital) ;
Laribi, Kamel (Centre Hospitalier du Mans) ;
Meddeb, Balkis (Aziza Othmana University Hospital) ;
Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ;
Raposo, Joäo (Hospital de Santa Maria) ;
Schuh, Anna (Oxford University Hospitals) ;
Ünal, Ali (Erciyes University Medical School) ;
Widenius, Tom (Peijas Hospital) ;
Bernhardt, Alf (F. Hoffmann-La Roche Ltd) ;
Kellershohn, Kerstin (Roche Pharma AG) ;
Messeri, Dimitri (F. Hoffmann-La Roche Ltd) ;
Osborne, Stuart (F. Hoffmann-La Roche Ltd) ;
Leblond, Véronique (UPMC University) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
